Cargando…
Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
Background Neodymium-doped yttrium aluminium garnet (Nd:YAG) posterior capsulotomy is a common treatment for posterior capsular opacification. Practice varies regarding routine follow-up. In this study, we reviewed follow-up rates and treatment-related complications from a district general hospital’...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893007/ https://www.ncbi.nlm.nih.gov/pubmed/35261829 http://dx.doi.org/10.7759/cureus.21803 |
_version_ | 1784662291964231680 |
---|---|
author | Richardson-May, James G La, Chuiki J Chihaia, Madalina A Clarke, Holly Light, Michelle Rashid, Mohammed |
author_facet | Richardson-May, James G La, Chuiki J Chihaia, Madalina A Clarke, Holly Light, Michelle Rashid, Mohammed |
author_sort | Richardson-May, James G |
collection | PubMed |
description | Background Neodymium-doped yttrium aluminium garnet (Nd:YAG) posterior capsulotomy is a common treatment for posterior capsular opacification. Practice varies regarding routine follow-up. In this study, we reviewed follow-up rates and treatment-related complications from a district general hospital’s ophthalmology unit to assess areas for improvement and cost-effectiveness. Methodology We conducted a retrospective review of electronic patient records for all patients treated with Nd:YAG capsulotomy in 2019 at our hospital. Primary outcomes included visual acuity, complications, and follow-up data. Secondary outcomes included medication prescribing and the grade of surgeon. Results In total, 912 eyes of 744 patients were included. Overall, 536 (58.8%) eyes were discharged immediately following their laser. Complication rate was 4.3% (39 eyes). Junior training grades had a higher rate of medication prescribing (40/46 eyes; 87.0%) and follow-up (36/40 eyes; 78.3%). Conclusions Certain selected patients may be safely discharged following capsulotomy with safety-netting advice. This strategy increases the capacity to follow-up patients at higher risk of complications. Higher rates of follow-up among junior ophthalmologists offers potential for training. |
format | Online Article Text |
id | pubmed-8893007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-88930072022-03-07 Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? Richardson-May, James G La, Chuiki J Chihaia, Madalina A Clarke, Holly Light, Michelle Rashid, Mohammed Cureus Ophthalmology Background Neodymium-doped yttrium aluminium garnet (Nd:YAG) posterior capsulotomy is a common treatment for posterior capsular opacification. Practice varies regarding routine follow-up. In this study, we reviewed follow-up rates and treatment-related complications from a district general hospital’s ophthalmology unit to assess areas for improvement and cost-effectiveness. Methodology We conducted a retrospective review of electronic patient records for all patients treated with Nd:YAG capsulotomy in 2019 at our hospital. Primary outcomes included visual acuity, complications, and follow-up data. Secondary outcomes included medication prescribing and the grade of surgeon. Results In total, 912 eyes of 744 patients were included. Overall, 536 (58.8%) eyes were discharged immediately following their laser. Complication rate was 4.3% (39 eyes). Junior training grades had a higher rate of medication prescribing (40/46 eyes; 87.0%) and follow-up (36/40 eyes; 78.3%). Conclusions Certain selected patients may be safely discharged following capsulotomy with safety-netting advice. This strategy increases the capacity to follow-up patients at higher risk of complications. Higher rates of follow-up among junior ophthalmologists offers potential for training. Cureus 2022-02-01 /pmc/articles/PMC8893007/ /pubmed/35261829 http://dx.doi.org/10.7759/cureus.21803 Text en Copyright © 2022, Richardson-May et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Ophthalmology Richardson-May, James G La, Chuiki J Chihaia, Madalina A Clarke, Holly Light, Michelle Rashid, Mohammed Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? |
title | Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? |
title_full | Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? |
title_fullStr | Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? |
title_full_unstemmed | Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? |
title_short | Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? |
title_sort | can routine patients be safely discharged after neodymium-doped yttrium aluminium garnet laser posterior capsulotomy? |
topic | Ophthalmology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893007/ https://www.ncbi.nlm.nih.gov/pubmed/35261829 http://dx.doi.org/10.7759/cureus.21803 |
work_keys_str_mv | AT richardsonmayjamesg canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy AT lachuikij canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy AT chihaiamadalinaa canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy AT clarkeholly canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy AT lightmichelle canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy AT rashidmohammed canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy |